BioCardia, Inc.
BCDA
$2.10
-$0.17-7.49%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -267.24% | 16.38% | |||
| Gross Profit | 267.24% | -16.81% | |||
| SG&A Expenses | 9.82% | -3.17% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 32.18% | 6.30% | |||
| Operating Income | -32.18% | -6.49% | |||
| Income Before Tax | -32.18% | -5.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -32.18% | -5.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -32.18% | -5.53% | |||
| EBIT | -32.18% | -6.49% | |||
| EBITDA | -32.53% | -6.62% | |||
| EPS Basic | 18.53% | 29.95% | |||
| Normalized Basic EPS | 18.54% | 29.94% | |||
| EPS Diluted | -63.34% | 29.95% | |||
| Normalized Diluted EPS | 18.54% | 29.94% | |||
| Average Basic Shares Outstanding | 62.25% | 50.63% | |||
| Average Diluted Shares Outstanding | 62.25% | 50.63% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
